| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Huntington Disease | 170 | 2024 | 1144 | 12.660 |
Why?
|
| Trinucleotide Repeat Expansion | 33 | 2022 | 247 | 3.040 |
Why?
|
| Chromosomes, Human, Pair 4 | 54 | 2015 | 375 | 2.810 |
Why?
|
| Trinucleotide Repeats | 24 | 2017 | 257 | 2.460 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 51 | 2010 | 783 | 2.290 |
Why?
|
| Nerve Tissue Proteins | 59 | 2019 | 4408 | 2.230 |
Why?
|
| Chromosome Mapping | 151 | 2024 | 4611 | 2.230 |
Why?
|
| Genetic Linkage | 106 | 2021 | 2340 | 2.220 |
Why?
|
| Genes, Neurofibromatosis 2 | 29 | 2007 | 122 | 1.760 |
Why?
|
| Chromosomes, Human, Pair 9 | 29 | 2001 | 535 | 1.500 |
Why?
|
| Chromosome Disorders | 13 | 2022 | 497 | 1.490 |
Why?
|
| Polymorphism, Genetic | 83 | 2017 | 4242 | 1.490 |
Why?
|
| Translocation, Genetic | 30 | 2024 | 1392 | 1.460 |
Why?
|
| Chromosomes, Human, Pair 22 | 34 | 2005 | 346 | 1.430 |
Why?
|
| Chromosomes, Human, Pair 16 | 18 | 2022 | 343 | 1.360 |
Why?
|
| Genetic Markers | 94 | 2016 | 2601 | 1.310 |
Why?
|
| Haplotypes | 31 | 2023 | 2713 | 1.250 |
Why?
|
| Polymorphism, Restriction Fragment Length | 55 | 1996 | 767 | 1.230 |
Why?
|
| Chromosome Aberrations | 27 | 2021 | 1768 | 1.230 |
Why?
|
| Neurofibromin 2 | 25 | 2021 | 269 | 1.200 |
Why?
|
| DNA Copy Number Variations | 20 | 2022 | 2020 | 1.170 |
Why?
|
| Child Development Disorders, Pervasive | 10 | 2015 | 600 | 1.140 |
Why?
|
| Chromosome Deletion | 27 | 2023 | 1386 | 1.130 |
Why?
|
| Mutation | 84 | 2023 | 30015 | 1.060 |
Why?
|
| Alleles | 71 | 2021 | 6861 | 1.040 |
Why?
|
| Pedigree | 95 | 2021 | 4539 | 1.030 |
Why?
|
| Nuclear Proteins | 37 | 2015 | 5789 | 1.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 25 | 1993 | 228 | 1.010 |
Why?
|
| Neurofibromatosis 2 | 14 | 2021 | 383 | 0.960 |
Why?
|
| Dysautonomia, Familial | 12 | 2007 | 94 | 0.900 |
Why?
|
| Corpus Striatum | 10 | 2024 | 1235 | 0.900 |
Why?
|
| Base Sequence | 108 | 2017 | 12420 | 0.890 |
Why?
|
| Age of Onset | 46 | 2022 | 3303 | 0.860 |
Why?
|
| Sequence Deletion | 15 | 2018 | 1490 | 0.840 |
Why?
|
| Meningioma | 23 | 2021 | 1215 | 0.830 |
Why?
|
| Chromosomes, Human, Pair 2 | 11 | 2013 | 313 | 0.830 |
Why?
|
| Neurilemmoma | 13 | 2021 | 524 | 0.790 |
Why?
|
| Molecular Sequence Data | 115 | 2015 | 17630 | 0.780 |
Why?
|
| Genes, Neurofibromatosis 1 | 7 | 2010 | 74 | 0.780 |
Why?
|
| Heterozygote | 30 | 2024 | 2780 | 0.770 |
Why?
|
| Neurofibromatosis 1 | 15 | 2010 | 560 | 0.770 |
Why?
|
| Receptors, Kainic Acid | 4 | 2024 | 91 | 0.770 |
Why?
|
| Phenotype | 58 | 2023 | 16572 | 0.760 |
Why?
|
| Exons | 28 | 2024 | 2381 | 0.730 |
Why?
|
| Neurons | 24 | 2024 | 9436 | 0.700 |
Why?
|
| Developmental Disabilities | 15 | 2021 | 1509 | 0.690 |
Why?
|
| Induced Pluripotent Stem Cells | 11 | 2023 | 1851 | 0.690 |
Why?
|
| Kallmann Syndrome | 6 | 2020 | 139 | 0.680 |
Why?
|
| DNA | 74 | 2022 | 7196 | 0.660 |
Why?
|
| Meningeal Neoplasms | 16 | 2021 | 1245 | 0.640 |
Why?
|
| Autistic Disorder | 12 | 2022 | 1219 | 0.630 |
Why?
|
| Genetic Predisposition to Disease | 33 | 2021 | 17878 | 0.630 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2020 | 183 | 0.630 |
Why?
|
| Craniofacial Abnormalities | 3 | 2012 | 319 | 0.620 |
Why?
|
| Humans | 530 | 2024 | 760740 | 0.620 |
Why?
|
| Alternative Splicing | 9 | 2022 | 1088 | 0.610 |
Why?
|
| Sodium Channels | 7 | 2012 | 339 | 0.590 |
Why?
|
| Gene Rearrangement | 7 | 2017 | 1125 | 0.570 |
Why?
|
| Endodeoxyribonucleases | 4 | 2024 | 164 | 0.570 |
Why?
|
| Founder Effect | 7 | 2015 | 185 | 0.560 |
Why?
|
| Sequence Analysis, DNA | 24 | 2024 | 4739 | 0.560 |
Why?
|
| Exodeoxyribonucleases | 4 | 2024 | 191 | 0.560 |
Why?
|
| Codon, Nonsense | 4 | 2020 | 284 | 0.550 |
Why?
|
| Chromosomes, Human | 4 | 2014 | 441 | 0.550 |
Why?
|
| 3' Untranslated Regions | 6 | 2024 | 516 | 0.550 |
Why?
|
| Peptides | 16 | 2023 | 4354 | 0.540 |
Why?
|
| Mutation, Missense | 15 | 2021 | 2570 | 0.540 |
Why?
|
| Genetics, Medical | 4 | 2017 | 334 | 0.530 |
Why?
|
| Disease Susceptibility | 5 | 2021 | 1788 | 0.500 |
Why?
|
| Dictyostelium | 3 | 2014 | 70 | 0.500 |
Why?
|
| Polymerase Chain Reaction | 48 | 2015 | 6074 | 0.490 |
Why?
|
| Ornithine-Oxo-Acid Transaminase | 9 | 1992 | 49 | 0.480 |
Why?
|
| DNA-Binding Proteins | 18 | 2021 | 9586 | 0.470 |
Why?
|
| Chromosomes, Human, Pair 3 | 5 | 2007 | 322 | 0.470 |
Why?
|
| Chromosomes, Human, Pair 8 | 7 | 2018 | 453 | 0.460 |
Why?
|
| Genotype | 39 | 2019 | 12977 | 0.450 |
Why?
|
| Transcription Factors | 24 | 2020 | 12116 | 0.450 |
Why?
|
| Brain Chemistry | 9 | 2000 | 960 | 0.450 |
Why?
|
| Parkinson Disease | 15 | 2011 | 2878 | 0.450 |
Why?
|
| Cloning, Molecular | 41 | 2001 | 4172 | 0.450 |
Why?
|
| Codon, Terminator | 2 | 2012 | 124 | 0.430 |
Why?
|
| Genome-Wide Association Study | 24 | 2024 | 12661 | 0.430 |
Why?
|
| Genetic Association Studies | 8 | 2021 | 2734 | 0.430 |
Why?
|
| Transcription, Genetic | 20 | 2022 | 7583 | 0.420 |
Why?
|
| Inverted Repeat Sequences | 1 | 2013 | 60 | 0.420 |
Why?
|
| Cell Line | 47 | 2021 | 15577 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 11 | 4 | 2012 | 410 | 0.420 |
Why?
|
| Animals | 152 | 2024 | 168202 | 0.420 |
Why?
|
| Awards and Prizes | 1 | 2017 | 360 | 0.410 |
Why?
|
| Membrane Proteins | 24 | 2017 | 7847 | 0.410 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 2 | 2013 | 263 | 0.400 |
Why?
|
| Polymorphism, Single Nucleotide | 26 | 2020 | 15908 | 0.400 |
Why?
|
| Chromosome Breakage | 7 | 2012 | 159 | 0.390 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 11 | 1993 | 166 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 15 | 5 | 2018 | 361 | 0.390 |
Why?
|
| DNA, Recombinant | 17 | 1988 | 455 | 0.390 |
Why?
|
| Recombination, Genetic | 20 | 2011 | 1519 | 0.380 |
Why?
|
| Haploinsufficiency | 6 | 2022 | 336 | 0.380 |
Why?
|
| Lod Score | 23 | 2013 | 600 | 0.380 |
Why?
|
| Genetic Testing | 13 | 2016 | 3533 | 0.380 |
Why?
|
| Diseases in Twins | 3 | 2010 | 446 | 0.380 |
Why?
|
| Energy Metabolism | 4 | 2020 | 2878 | 0.370 |
Why?
|
| Genes | 18 | 1999 | 1823 | 0.370 |
Why?
|
| DNA Mutational Analysis | 29 | 2014 | 4110 | 0.370 |
Why?
|
| Genetic Diseases, Inborn | 8 | 2003 | 604 | 0.360 |
Why?
|
| Gonadotropin-Releasing Hormone | 6 | 2020 | 1148 | 0.360 |
Why?
|
| Mental Retardation, X-Linked | 2 | 2009 | 41 | 0.350 |
Why?
|
| Mice | 87 | 2023 | 81368 | 0.350 |
Why?
|
| Disease Models, Animal | 21 | 2024 | 18220 | 0.350 |
Why?
|
| Gene Frequency | 25 | 2019 | 3601 | 0.350 |
Why?
|
| Chromosomes, Human, Pair 5 | 5 | 2016 | 386 | 0.340 |
Why?
|
| Chromosomes, Human, 21-22 and Y | 9 | 1986 | 45 | 0.340 |
Why?
|
| Cyclin-Dependent Kinase 5 | 2 | 2023 | 112 | 0.340 |
Why?
|
| Family Health | 9 | 2018 | 1253 | 0.340 |
Why?
|
| Genetic Pleiotropy | 1 | 2011 | 181 | 0.340 |
Why?
|
| Cadherins | 4 | 2022 | 901 | 0.330 |
Why?
|
| Abnormalities, Multiple | 10 | 2017 | 1422 | 0.330 |
Why?
|
| Oligodeoxyribonucleotides | 20 | 1994 | 704 | 0.330 |
Why?
|
| Chromosomes, Human, Pair 17 | 10 | 2008 | 418 | 0.330 |
Why?
|
| Male | 204 | 2021 | 360402 | 0.330 |
Why?
|
| Brain | 36 | 2021 | 27100 | 0.330 |
Why?
|
| Genome, Human | 17 | 2022 | 4421 | 0.320 |
Why?
|
| Protozoan Proteins | 2 | 2014 | 846 | 0.320 |
Why?
|
| Arachnoid | 2 | 2009 | 50 | 0.320 |
Why?
|
| Hybrid Cells | 27 | 2000 | 422 | 0.320 |
Why?
|
| Brain-Derived Neurotrophic Factor | 3 | 2009 | 602 | 0.310 |
Why?
|
| Gene Expression Regulation, Developmental | 10 | 2020 | 3606 | 0.310 |
Why?
|
| RNA, Messenger | 41 | 2021 | 12759 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 19 | 8 | 1999 | 350 | 0.310 |
Why?
|
| Neoplasm Proteins | 13 | 2024 | 3607 | 0.300 |
Why?
|
| Mosaicism | 6 | 2016 | 474 | 0.300 |
Why?
|
| Carrier Proteins | 12 | 2015 | 4937 | 0.300 |
Why?
|
| Alzheimer Disease | 28 | 2012 | 8603 | 0.300 |
Why?
|
| Language Development Disorders | 4 | 2020 | 193 | 0.300 |
Why?
|
| Germ-Line Mutation | 8 | 2018 | 1852 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 10 | 7 | 2010 | 277 | 0.290 |
Why?
|
| Amyloid | 9 | 1998 | 841 | 0.290 |
Why?
|
| Histone Deacetylases | 1 | 2012 | 719 | 0.290 |
Why?
|
| DNA, Neoplasm | 16 | 1999 | 1743 | 0.290 |
Why?
|
| Transaminases | 5 | 1988 | 199 | 0.290 |
Why?
|
| Evolution, Molecular | 2 | 2015 | 1880 | 0.290 |
Why?
|
| Female | 198 | 2021 | 392203 | 0.290 |
Why?
|
| Gene Expression Regulation | 24 | 2021 | 11874 | 0.290 |
Why?
|
| Amino Acid Sequence | 40 | 2021 | 13442 | 0.290 |
Why?
|
| Neuroma, Acoustic | 8 | 2000 | 458 | 0.290 |
Why?
|
| Gingival Hyperplasia | 1 | 2007 | 19 | 0.290 |
Why?
|
| DNA Probes | 21 | 1993 | 541 | 0.280 |
Why?
|
| Animals, Genetically Modified | 8 | 2024 | 1557 | 0.280 |
Why?
|
| Hypertrichosis | 1 | 2007 | 31 | 0.280 |
Why?
|
| Cell Differentiation | 15 | 2023 | 11512 | 0.280 |
Why?
|
| Dystonia Musculorum Deformans | 8 | 2001 | 158 | 0.270 |
Why?
|
| DNA Restriction Enzymes | 26 | 1992 | 550 | 0.270 |
Why?
|
| Homozygote | 7 | 2024 | 1776 | 0.270 |
Why?
|
| Chromosome Inversion | 4 | 2016 | 120 | 0.260 |
Why?
|
| Models, Organizational | 1 | 2009 | 544 | 0.260 |
Why?
|
| Linkage Disequilibrium | 12 | 2008 | 1994 | 0.260 |
Why?
|
| Chromosomes, Human, 4-5 | 5 | 1985 | 26 | 0.260 |
Why?
|
| Segmental Duplications, Genomic | 2 | 2016 | 19 | 0.260 |
Why?
|
| Neural Stem Cells | 5 | 2022 | 887 | 0.260 |
Why?
|
| Cytoskeletal Proteins | 8 | 2013 | 1336 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 7 | 8 | 2020 | 310 | 0.260 |
Why?
|
| Ring Chromosomes | 2 | 2024 | 26 | 0.260 |
Why?
|
| Congenital Abnormalities | 4 | 2016 | 709 | 0.250 |
Why?
|
| Molecular Biology | 5 | 2000 | 575 | 0.250 |
Why?
|
| Hand Deformities, Congenital | 2 | 2017 | 174 | 0.250 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 2010 | 257 | 0.250 |
Why?
|
| Restriction Mapping | 13 | 2003 | 851 | 0.250 |
Why?
|
| Gene Dosage | 7 | 2022 | 1217 | 0.250 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2024 | 894 | 0.250 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 4 | 2013 | 134 | 0.240 |
Why?
|
| Neostriatum | 4 | 2012 | 247 | 0.240 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 2 | 2016 | 88 | 0.240 |
Why?
|
| Neuropeptides | 3 | 2010 | 944 | 0.240 |
Why?
|
| Comparative Genomic Hybridization | 10 | 2017 | 473 | 0.240 |
Why?
|
| Proteins | 14 | 2018 | 6030 | 0.240 |
Why?
|
| Telomere | 6 | 2024 | 942 | 0.240 |
Why?
|
| Basal Ganglia Diseases | 1 | 2005 | 145 | 0.240 |
Why?
|
| Sequence Tagged Sites | 3 | 1993 | 96 | 0.240 |
Why?
|
| Spermatozoa | 5 | 2016 | 629 | 0.230 |
Why?
|
| MicroRNAs | 5 | 2024 | 3802 | 0.230 |
Why?
|
| Receptors, LHRH | 3 | 2015 | 158 | 0.230 |
Why?
|
| Mutant Proteins | 2 | 2011 | 489 | 0.230 |
Why?
|
| Neurofibromatoses | 4 | 2018 | 299 | 0.230 |
Why?
|
| Cytokinins | 1 | 2004 | 25 | 0.230 |
Why?
|
| Biotin | 1 | 2005 | 252 | 0.230 |
Why?
|
| Karyotyping | 13 | 2016 | 1171 | 0.220 |
Why?
|
| Jews | 8 | 2003 | 356 | 0.220 |
Why?
|
| Receptors, Peptide | 3 | 2015 | 279 | 0.220 |
Why?
|
| Adult | 102 | 2021 | 220995 | 0.220 |
Why?
|
| Gene Expression | 19 | 2021 | 7569 | 0.220 |
Why?
|
| Mental Disorders | 6 | 2021 | 6826 | 0.220 |
Why?
|
| Muscles | 3 | 1993 | 1573 | 0.220 |
Why?
|
| Loss of Heterozygosity | 5 | 2005 | 662 | 0.220 |
Why?
|
| Repetitive Sequences, Amino Acid | 2 | 2002 | 92 | 0.220 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2012 | 3776 | 0.220 |
Why?
|
| Self-Injurious Behavior | 1 | 2009 | 566 | 0.210 |
Why?
|
| Models, Genetic | 14 | 2013 | 3431 | 0.210 |
Why?
|
| Gene Expression Profiling | 11 | 2024 | 9417 | 0.210 |
Why?
|
| Mice, Transgenic | 13 | 2020 | 9526 | 0.210 |
Why?
|
| Neural Tube Defects | 2 | 2017 | 255 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2018 | 8542 | 0.210 |
Why?
|
| RNA Precursors | 1 | 2004 | 200 | 0.210 |
Why?
|
| Amyloid beta-Protein Precursor | 10 | 2012 | 1111 | 0.210 |
Why?
|
| Cleft Palate | 3 | 2016 | 589 | 0.210 |
Why?
|
| Molecular Chaperones | 4 | 2013 | 754 | 0.200 |
Why?
|
| Gene Deletion | 12 | 2018 | 2659 | 0.200 |
Why?
|
| Hypogonadism | 4 | 2010 | 798 | 0.200 |
Why?
|
| X Chromosome | 6 | 2021 | 816 | 0.200 |
Why?
|
| Zebrafish | 10 | 2016 | 3005 | 0.200 |
Why?
|
| Potassium Channels | 2 | 2016 | 537 | 0.200 |
Why?
|
| Adenine | 2 | 2006 | 985 | 0.190 |
Why?
|
| In Situ Hybridization, Fluorescence | 10 | 2017 | 2509 | 0.190 |
Why?
|
| RNA Splicing | 7 | 2021 | 898 | 0.190 |
Why?
|
| Cell Nucleus | 7 | 2024 | 2894 | 0.190 |
Why?
|
| Drosophila Proteins | 4 | 2014 | 1698 | 0.190 |
Why?
|
| RNA | 10 | 2022 | 2713 | 0.190 |
Why?
|
| Sequence Homology, Amino Acid | 13 | 2011 | 2747 | 0.190 |
Why?
|
| Metabolome | 2 | 2020 | 988 | 0.190 |
Why?
|
| Nervous System Neoplasms | 2 | 1995 | 91 | 0.190 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 3419 | 0.190 |
Why?
|
| Sheep | 4 | 2024 | 1436 | 0.190 |
Why?
|
| Cerebral Cortex | 8 | 2022 | 5776 | 0.190 |
Why?
|
| Gene Targeting | 5 | 2020 | 837 | 0.180 |
Why?
|
| Fragile X Syndrome | 2 | 2020 | 116 | 0.180 |
Why?
|
| Prenatal Diagnosis | 5 | 2016 | 1265 | 0.180 |
Why?
|
| Child | 50 | 2021 | 80089 | 0.180 |
Why?
|
| Genome | 7 | 2022 | 1737 | 0.180 |
Why?
|
| Syndrome | 11 | 2016 | 3268 | 0.180 |
Why?
|
| Motor Skills Disorders | 1 | 2021 | 89 | 0.180 |
Why?
|
| Gene Library | 8 | 2015 | 1055 | 0.180 |
Why?
|
| Ribonucleotide Reductases | 1 | 2020 | 76 | 0.180 |
Why?
|
| DNA Helicases | 5 | 2014 | 851 | 0.180 |
Why?
|
| Cerebellum | 5 | 2016 | 1501 | 0.180 |
Why?
|
| Mitochondria | 5 | 2020 | 3619 | 0.180 |
Why?
|
| Signal Transduction | 14 | 2020 | 23415 | 0.180 |
Why?
|
| Nervous System | 2 | 2012 | 545 | 0.180 |
Why?
|
| Chromosomal Proteins, Non-Histone | 3 | 2017 | 725 | 0.170 |
Why?
|
| Neurodegenerative Diseases | 4 | 2014 | 1085 | 0.170 |
Why?
|
| Organophosphorus Compounds | 1 | 2021 | 206 | 0.170 |
Why?
|
| Muscle Hypotonia | 3 | 2016 | 161 | 0.170 |
Why?
|
| Receptors, Cell Surface | 5 | 2016 | 2802 | 0.170 |
Why?
|
| Glycoproteins | 2 | 2008 | 2200 | 0.170 |
Why?
|
| Neuregulin-1 | 1 | 2020 | 135 | 0.170 |
Why?
|
| Actins | 6 | 2011 | 2051 | 0.170 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2021 | 234 | 0.170 |
Why?
|
| Autocrine Communication | 1 | 2020 | 169 | 0.170 |
Why?
|
| Mediator Complex | 4 | 2015 | 106 | 0.170 |
Why?
|
| Cleft Lip | 1 | 2005 | 506 | 0.170 |
Why?
|
| Morphogenesis | 2 | 2016 | 741 | 0.170 |
Why?
|
| Receptor, erbB-3 | 1 | 2020 | 143 | 0.170 |
Why?
|
| Penetrance | 3 | 2015 | 382 | 0.170 |
Why?
|
| Genetic Variation | 9 | 2011 | 6561 | 0.170 |
Why?
|
| Uniparental Disomy | 1 | 2019 | 45 | 0.170 |
Why?
|
| Head | 3 | 2016 | 922 | 0.170 |
Why?
|
| Middle Aged | 86 | 2021 | 220603 | 0.170 |
Why?
|
| Glioma | 7 | 2018 | 3452 | 0.170 |
Why?
|
| DNA, Complementary | 12 | 2012 | 1989 | 0.170 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 1034 | 0.160 |
Why?
|
| DNA, Single-Stranded | 8 | 2013 | 353 | 0.160 |
Why?
|
| Retinal Degeneration | 3 | 1988 | 414 | 0.160 |
Why?
|
| Phosphoproteins | 5 | 2002 | 2445 | 0.160 |
Why?
|
| Nucleic Acid Hybridization | 22 | 1993 | 1301 | 0.160 |
Why?
|
| Child, Preschool | 28 | 2021 | 42193 | 0.160 |
Why?
|
| Adolescent | 48 | 2019 | 88247 | 0.160 |
Why?
|
| Genes, Dominant | 12 | 2002 | 851 | 0.160 |
Why?
|
| Mucolipidoses | 1 | 1999 | 82 | 0.160 |
Why?
|
| Testis | 2 | 2016 | 792 | 0.160 |
Why?
|
| Genes, Recessive | 7 | 2016 | 623 | 0.160 |
Why?
|
| Glutamic Acid | 1 | 2024 | 1175 | 0.160 |
Why?
|
| Dystonia | 2 | 2021 | 370 | 0.160 |
Why?
|
| Receptors, Eph Family | 1 | 2018 | 45 | 0.160 |
Why?
|
| Ear Neoplasms | 1 | 1999 | 118 | 0.150 |
Why?
|
| Suicide | 1 | 2009 | 1601 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2015 | 1250 | 0.150 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2020 | 380 | 0.150 |
Why?
|
| Rett Syndrome | 1 | 2020 | 163 | 0.150 |
Why?
|
| Oxidative Phosphorylation | 1 | 2020 | 495 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 5 | 2022 | 2013 | 0.150 |
Why?
|
| Lymphocytes | 10 | 2012 | 2604 | 0.150 |
Why?
|
| Chromosome Duplication | 2 | 2016 | 75 | 0.150 |
Why?
|
| Sequence Alignment | 9 | 2021 | 2178 | 0.150 |
Why?
|
| Fibroblasts | 11 | 2017 | 4140 | 0.150 |
Why?
|
| Crossing Over, Genetic | 8 | 1995 | 92 | 0.150 |
Why?
|
| DNA, Satellite | 3 | 1995 | 66 | 0.150 |
Why?
|
| Iduronidase | 3 | 1992 | 31 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 6 | 3 | 2006 | 367 | 0.150 |
Why?
|
| Neural Crest | 2 | 2020 | 278 | 0.150 |
Why?
|
| Myelin Sheath | 1 | 2021 | 653 | 0.140 |
Why?
|
| Chromosomes, Human, 6-12 and X | 4 | 1984 | 69 | 0.140 |
Why?
|
| Zebrafish Proteins | 5 | 2015 | 1013 | 0.140 |
Why?
|
| Protein Precursors | 7 | 1990 | 1131 | 0.140 |
Why?
|
| Nucleotides | 3 | 2016 | 453 | 0.140 |
Why?
|
| Venezuela | 7 | 2018 | 73 | 0.140 |
Why?
|
| Receptors, Purinergic P1 | 2 | 1996 | 108 | 0.140 |
Why?
|
| Cockayne Syndrome | 1 | 2017 | 20 | 0.140 |
Why?
|
| Muscular Dystrophies | 3 | 2017 | 390 | 0.140 |
Why?
|
| Cell Cycle Proteins | 2 | 2020 | 3447 | 0.140 |
Why?
|
| Down Syndrome | 11 | 1991 | 901 | 0.140 |
Why?
|
| Transcriptional Elongation Factors | 5 | 2007 | 165 | 0.140 |
Why?
|
| Dystonic Disorders | 1 | 2021 | 350 | 0.140 |
Why?
|
| Sheep, Domestic | 2 | 2016 | 50 | 0.140 |
Why?
|
| Choanal Atresia | 1 | 2017 | 41 | 0.140 |
Why?
|
| Trisomy | 3 | 2013 | 260 | 0.140 |
Why?
|
| Neurobiology | 1 | 1998 | 137 | 0.140 |
Why?
|
| Neuropsychological Tests | 3 | 2021 | 7050 | 0.140 |
Why?
|
| Restless Legs Syndrome | 2 | 2012 | 233 | 0.140 |
Why?
|
| Microphthalmos | 1 | 2017 | 58 | 0.140 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 1894 | 0.140 |
Why?
|
| DNA Repeat Expansion | 3 | 2008 | 72 | 0.140 |
Why?
|
| Phosphotransferases | 1 | 2017 | 303 | 0.130 |
Why?
|
| CHARGE Syndrome | 2 | 2014 | 34 | 0.130 |
Why?
|
| Microfilament Proteins | 7 | 2005 | 1130 | 0.130 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 9 | 2000 | 329 | 0.130 |
Why?
|
| CapZ Actin Capping Protein | 1 | 2016 | 11 | 0.130 |
Why?
|
| Genes, Homeobox | 2 | 2015 | 286 | 0.130 |
Why?
|
| Blotting, Southern | 11 | 2007 | 777 | 0.130 |
Why?
|
| Cell Adhesion | 2 | 2014 | 3088 | 0.130 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 1999 | 269 | 0.130 |
Why?
|
| Growth Differentiation Factor 6 | 1 | 2015 | 8 | 0.130 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 1135 | 0.130 |
Why?
|
| Glycolysis | 1 | 2020 | 835 | 0.130 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2016 | 94 | 0.130 |
Why?
|
| Case-Control Studies | 14 | 2015 | 22153 | 0.130 |
Why?
|
| Genes, Developmental | 1 | 2015 | 38 | 0.130 |
Why?
|
| Tuberous Sclerosis | 4 | 2020 | 1031 | 0.130 |
Why?
|
| Pyrimidines | 4 | 2021 | 3027 | 0.130 |
Why?
|
| Foot Deformities, Congenital | 1 | 2015 | 59 | 0.130 |
Why?
|
| Hedgehog Proteins | 2 | 2018 | 768 | 0.130 |
Why?
|
| Stapes | 1 | 2015 | 89 | 0.130 |
Why?
|
| Synostosis | 1 | 2015 | 43 | 0.130 |
Why?
|
| Kinetin | 2 | 2007 | 22 | 0.130 |
Why?
|
| Wnt Proteins | 3 | 2009 | 718 | 0.130 |
Why?
|
| Cell Proliferation | 9 | 2020 | 10429 | 0.130 |
Why?
|
| Genomic Instability | 3 | 2017 | 709 | 0.130 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2018 | 2872 | 0.130 |
Why?
|
| Urea | 1 | 2017 | 443 | 0.130 |
Why?
|
| Histones | 3 | 2022 | 2577 | 0.130 |
Why?
|
| Carpal Bones | 1 | 2015 | 75 | 0.120 |
Why?
|
| Skin Neoplasms | 7 | 2018 | 5811 | 0.120 |
Why?
|
| Receptors, Dopamine | 2 | 2013 | 296 | 0.120 |
Why?
|
| Internationality | 1 | 2021 | 1000 | 0.120 |
Why?
|
| Adenosine Triphosphate | 2 | 2020 | 1988 | 0.120 |
Why?
|
| Tarsal Bones | 1 | 2015 | 70 | 0.120 |
Why?
|
| DNA Repair Enzymes | 1 | 2017 | 346 | 0.120 |
Why?
|
| Neurokinin B | 1 | 2015 | 67 | 0.120 |
Why?
|
| Facial Expression | 2 | 2009 | 508 | 0.120 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2015 | 38 | 0.120 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 1169 | 0.120 |
Why?
|
| Drosophila | 3 | 2014 | 1494 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2020 | 2057 | 0.120 |
Why?
|
| Microcephaly | 3 | 2016 | 425 | 0.120 |
Why?
|
| Cricetinae | 14 | 1992 | 2424 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2021 | 4569 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 8 | 2024 | 3634 | 0.120 |
Why?
|
| Proton-Translocating ATPases | 1 | 1994 | 112 | 0.120 |
Why?
|
| Microsatellite Repeats | 8 | 2012 | 783 | 0.120 |
Why?
|
| Frontotemporal Dementia | 1 | 2017 | 245 | 0.120 |
Why?
|
| Deficiency Diseases | 1 | 2014 | 74 | 0.120 |
Why?
|
| Tight Junctions | 1 | 2017 | 324 | 0.120 |
Why?
|
| Hypothalamic Diseases | 1 | 2015 | 134 | 0.120 |
Why?
|
| Cytoskeleton | 4 | 2007 | 1170 | 0.120 |
Why?
|
| Edetic Acid | 2 | 2014 | 276 | 0.110 |
Why?
|
| Aged | 57 | 2021 | 169092 | 0.110 |
Why?
|
| Puberty | 2 | 2010 | 501 | 0.110 |
Why?
|
| Hypokalemia | 2 | 1996 | 153 | 0.110 |
Why?
|
| Nerve Net | 2 | 2021 | 2290 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2010 | 4512 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2009 | 3426 | 0.110 |
Why?
|
| Genomic Library | 2 | 2012 | 189 | 0.110 |
Why?
|
| Chromatin | 5 | 2022 | 2955 | 0.110 |
Why?
|
| Morpholines | 4 | 2020 | 581 | 0.110 |
Why?
|
| Tauopathies | 1 | 2017 | 319 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 1 | 7 | 2016 | 638 | 0.110 |
Why?
|
| Embryo Implantation | 1 | 2015 | 270 | 0.110 |
Why?
|
| Embryonic Stem Cells | 4 | 2017 | 1262 | 0.110 |
Why?
|
| Schizophrenia | 5 | 2015 | 6929 | 0.110 |
Why?
|
| Serine Proteases | 1 | 2013 | 50 | 0.110 |
Why?
|
| Depressive Disorder, Major | 2 | 2015 | 4764 | 0.110 |
Why?
|
| Aminopeptidases | 1 | 2013 | 95 | 0.110 |
Why?
|
| Cytogenetic Analysis | 1 | 2014 | 270 | 0.110 |
Why?
|
| Gene Duplication | 5 | 2017 | 314 | 0.110 |
Why?
|
| Brain Neoplasms | 11 | 1995 | 9026 | 0.110 |
Why?
|
| Cells, Cultured | 12 | 2021 | 18937 | 0.110 |
Why?
|
| Terminal Repeat Sequences | 1 | 2013 | 70 | 0.110 |
Why?
|
| Nose | 1 | 2017 | 521 | 0.110 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2015 | 216 | 0.110 |
Why?
|
| Autopsy | 5 | 2017 | 1008 | 0.110 |
Why?
|
| Amino Acid Substitution | 3 | 2015 | 1739 | 0.110 |
Why?
|
| Leukoencephalopathies | 1 | 2016 | 256 | 0.110 |
Why?
|
| Medulloblastoma | 1 | 2018 | 677 | 0.110 |
Why?
|
| Heat-Shock Proteins | 2 | 2012 | 795 | 0.100 |
Why?
|
| Nevus | 1 | 1994 | 205 | 0.100 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2013 | 122 | 0.100 |
Why?
|
| Point Mutation | 9 | 2005 | 1595 | 0.100 |
Why?
|
| Leukemia, Erythroblastic, Acute | 3 | 1982 | 176 | 0.100 |
Why?
|
| Aortic Coarctation | 1 | 2015 | 275 | 0.100 |
Why?
|
| Neuroepithelial Cells | 1 | 2012 | 23 | 0.100 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2012 | 29 | 0.100 |
Why?
|
| Caudate Nucleus | 6 | 2012 | 390 | 0.100 |
Why?
|
| Chromosome Banding | 10 | 2007 | 260 | 0.100 |
Why?
|
| Immediate-Early Proteins | 1 | 2015 | 444 | 0.100 |
Why?
|
| Genomics | 4 | 2023 | 5822 | 0.100 |
Why?
|
| Organ Specificity | 7 | 2016 | 1964 | 0.100 |
Why?
|
| Paralyses, Familial Periodic | 2 | 1992 | 13 | 0.100 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 2 | 2011 | 324 | 0.100 |
Why?
|
| Protein Kinase C | 1 | 2017 | 1202 | 0.100 |
Why?
|
| Erythropoiesis | 5 | 1982 | 684 | 0.100 |
Why?
|
| SOXD Transcription Factors | 1 | 2012 | 44 | 0.100 |
Why?
|
| Cosmids | 9 | 1997 | 105 | 0.100 |
Why?
|
| Tissue Distribution | 7 | 2010 | 2261 | 0.100 |
Why?
|
| Heterochromatin | 1 | 2014 | 291 | 0.100 |
Why?
|
| Seizures | 4 | 2016 | 2964 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 6 | 2014 | 3793 | 0.100 |
Why?
|
| Homeodomain Proteins | 3 | 2019 | 2413 | 0.100 |
Why?
|
| Cognition Disorders | 2 | 2021 | 3979 | 0.100 |
Why?
|
| Cohort Studies | 17 | 2018 | 41464 | 0.100 |
Why?
|
| NFI Transcription Factors | 2 | 2012 | 42 | 0.100 |
Why?
|
| Spores, Protozoan | 1 | 2011 | 5 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2018 | 2896 | 0.100 |
Why?
|
| Genetic Engineering | 2 | 2016 | 931 | 0.100 |
Why?
|
| Thymidine Kinase | 1 | 1992 | 286 | 0.090 |
Why?
|
| Retinal Diseases | 2 | 2000 | 704 | 0.090 |
Why?
|
| DNA Primers | 12 | 2007 | 2817 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2017 | 2764 | 0.090 |
Why?
|
| Chromosome Breakpoints | 3 | 2016 | 93 | 0.090 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 1997 | 133 | 0.090 |
Why?
|
| Globins | 8 | 1982 | 405 | 0.090 |
Why?
|
| DNA Breaks | 1 | 2011 | 47 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 12 | 4 | 2020 | 430 | 0.090 |
Why?
|
| Cations, Divalent | 1 | 2011 | 168 | 0.090 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2011 | 53 | 0.090 |
Why?
|
| Meclizine | 1 | 2010 | 13 | 0.090 |
Why?
|
| Blotting, Northern | 9 | 2007 | 1545 | 0.090 |
Why?
|
| China | 4 | 2021 | 2374 | 0.090 |
Why?
|
| Protein Binding | 8 | 2018 | 9345 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 14 | 4 | 1997 | 286 | 0.090 |
Why?
|
| Minisatellite Repeats | 2 | 2011 | 163 | 0.090 |
Why?
|
| Osmotic Pressure | 1 | 2011 | 138 | 0.090 |
Why?
|
| Diacylglycerol Kinase | 2 | 2008 | 47 | 0.090 |
Why?
|
| Disease Management | 1 | 2021 | 2506 | 0.090 |
Why?
|
| Cataract | 3 | 2011 | 832 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 2 | 2013 | 1066 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2017 | 1566 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2019 | 2197 | 0.090 |
Why?
|
| Databases, Genetic | 3 | 2014 | 1742 | 0.090 |
Why?
|
| ADAM Proteins | 1 | 2012 | 238 | 0.090 |
Why?
|
| Cell Transformation, Viral | 3 | 1994 | 526 | 0.090 |
Why?
|
| Pluripotent Stem Cells | 1 | 2017 | 796 | 0.090 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2015 | 841 | 0.090 |
Why?
|
| Astrocytoma | 5 | 1995 | 774 | 0.090 |
Why?
|
| Mice, Mutant Strains | 5 | 2005 | 1748 | 0.090 |
Why?
|
| Acyltransferases | 2 | 2007 | 305 | 0.090 |
Why?
|
| Genomic Imprinting | 3 | 2008 | 329 | 0.090 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2011 | 132 | 0.090 |
Why?
|
| Histone Demethylases | 1 | 2013 | 323 | 0.090 |
Why?
|
| Drosophila melanogaster | 5 | 2012 | 1712 | 0.090 |
Why?
|
| Melatonin | 1 | 1995 | 669 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2014 | 1074 | 0.090 |
Why?
|
| RNA-Binding Proteins | 3 | 2015 | 1890 | 0.080 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2015 | 1462 | 0.080 |
Why?
|
| Goiter | 1 | 2010 | 87 | 0.080 |
Why?
|
| Models, Biological | 4 | 2021 | 9461 | 0.080 |
Why?
|
| Aged, 80 and over | 24 | 2016 | 58919 | 0.080 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2019 | 1394 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 8 | 2018 | 6126 | 0.080 |
Why?
|
| Introns | 5 | 2006 | 968 | 0.080 |
Why?
|
| Chromosomes, Human, 1-3 | 2 | 1986 | 21 | 0.080 |
Why?
|
| Hearing Loss | 1 | 2016 | 781 | 0.080 |
Why?
|
| Cilia | 1 | 2013 | 492 | 0.080 |
Why?
|
| Spinal Cord Neoplasms | 1 | 1991 | 261 | 0.080 |
Why?
|
| Chromosomes, Fungal | 4 | 1993 | 111 | 0.080 |
Why?
|
| gamma-Glutamyltransferase | 1 | 1988 | 144 | 0.080 |
Why?
|
| Hyperkalemia | 1 | 1991 | 233 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 1996 | 1058 | 0.080 |
Why?
|
| Neuroblastoma | 3 | 1993 | 1248 | 0.080 |
Why?
|
| Rats | 18 | 2014 | 23716 | 0.080 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 1988 | 21 | 0.080 |
Why?
|
| Behavior, Animal | 1 | 2016 | 1872 | 0.080 |
Why?
|
| Motor Cortex | 1 | 2016 | 1007 | 0.080 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 470 | 0.080 |
Why?
|
| Body Dysmorphic Disorders | 1 | 2012 | 243 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2008 | 502 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 2016 | 2208 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2005 | 1056 | 0.070 |
Why?
|
| Chemotaxis | 1 | 2011 | 598 | 0.070 |
Why?
|
| Pyridoxine | 1 | 1988 | 108 | 0.070 |
Why?
|
| Cell Line, Tumor | 7 | 2021 | 16968 | 0.070 |
Why?
|
| Thinness | 1 | 2011 | 480 | 0.070 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2012 | 620 | 0.070 |
Why?
|
| Cytosine | 2 | 2006 | 211 | 0.070 |
Why?
|
| In Situ Hybridization | 7 | 2010 | 1900 | 0.070 |
Why?
|
| Gene Knock-In Techniques | 3 | 2017 | 420 | 0.070 |
Why?
|
| Catenins | 1 | 2007 | 44 | 0.070 |
Why?
|
| Reproduction | 1 | 2012 | 646 | 0.070 |
Why?
|
| Macromolecular Substances | 3 | 2002 | 1433 | 0.070 |
Why?
|
| Gyrate Atrophy | 3 | 1992 | 16 | 0.070 |
Why?
|
| Infant | 18 | 2017 | 36157 | 0.070 |
Why?
|
| Young Adult | 13 | 2016 | 59191 | 0.070 |
Why?
|
| Crosses, Genetic | 3 | 1994 | 750 | 0.070 |
Why?
|
| Biological Evolution | 2 | 2012 | 1070 | 0.070 |
Why?
|
| Guanine | 2 | 2006 | 278 | 0.070 |
Why?
|
| Cognition | 2 | 2022 | 6988 | 0.070 |
Why?
|
| Bromodeoxyuridine | 1 | 2007 | 310 | 0.070 |
Why?
|
| Haploidy | 1 | 2007 | 126 | 0.070 |
Why?
|
| Inheritance Patterns | 1 | 2009 | 341 | 0.070 |
Why?
|
| Synaptotagmins | 1 | 2007 | 53 | 0.070 |
Why?
|
| Uveal Diseases | 1 | 1986 | 45 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2015 | 1028 | 0.070 |
Why?
|
| Cyclic AMP | 3 | 2003 | 1463 | 0.070 |
Why?
|
| Genetic Techniques | 3 | 2006 | 428 | 0.070 |
Why?
|
| alpha 1-Antichymotrypsin | 2 | 1996 | 19 | 0.070 |
Why?
|
| Human Development | 1 | 2008 | 123 | 0.070 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2015 | 1551 | 0.070 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2006 | 16 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2014 | 1528 | 0.070 |
Why?
|
| Neurofibromin 1 | 4 | 1997 | 190 | 0.070 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2006 | 99 | 0.070 |
Why?
|
| Avoidance Learning | 1 | 2008 | 247 | 0.070 |
Why?
|
| Obesity | 3 | 2016 | 12934 | 0.070 |
Why?
|
| Immunoblotting | 4 | 2015 | 1646 | 0.070 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2006 | 122 | 0.070 |
Why?
|
| Cell Transdifferentiation | 1 | 2007 | 186 | 0.070 |
Why?
|
| Colitis, Ulcerative | 1 | 1998 | 1921 | 0.070 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 3688 | 0.070 |
Why?
|
| Computational Biology | 4 | 2013 | 3509 | 0.070 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 1986 | 25 | 0.070 |
Why?
|
| Herbicides | 1 | 2006 | 105 | 0.070 |
Why?
|
| Chromosomes, Human, X | 1 | 2008 | 321 | 0.070 |
Why?
|
| Software | 5 | 2014 | 4432 | 0.070 |
Why?
|
| Crohn Disease | 1 | 1998 | 2279 | 0.060 |
Why?
|
| Glutathione Transferase | 4 | 2005 | 565 | 0.060 |
Why?
|
| Hippocampus | 3 | 2016 | 3762 | 0.060 |
Why?
|
| Chromosomes, Human, Y | 1 | 2007 | 161 | 0.060 |
Why?
|
| DNA Replication | 1 | 2013 | 1414 | 0.060 |
Why?
|
| Mutant Chimeric Proteins | 1 | 2005 | 20 | 0.060 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2009 | 793 | 0.060 |
Why?
|
| Anger | 1 | 2008 | 406 | 0.060 |
Why?
|
| Peptide Fragments | 5 | 2023 | 5109 | 0.060 |
Why?
|
| Family | 6 | 2018 | 3193 | 0.060 |
Why?
|
| Ependymoma | 3 | 1995 | 320 | 0.060 |
Why?
|
| Cell Death | 2 | 2024 | 1677 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 3 | 2015 | 1608 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2015 | 1795 | 0.060 |
Why?
|
| Precipitin Tests | 3 | 2002 | 813 | 0.060 |
Why?
|
| Long QT Syndrome | 1 | 2010 | 466 | 0.060 |
Why?
|
| Models, Neurological | 1 | 2013 | 1768 | 0.060 |
Why?
|
| HEK293 Cells | 3 | 2020 | 4269 | 0.060 |
Why?
|
| Calcium Channels | 2 | 2007 | 620 | 0.060 |
Why?
|
| Glycine | 1 | 2008 | 661 | 0.060 |
Why?
|
| Gossypol | 1 | 2005 | 23 | 0.060 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 242 | 0.060 |
Why?
|
| Cell Line, Transformed | 2 | 2005 | 866 | 0.060 |
Why?
|
| Oxidoreductases | 1 | 1987 | 412 | 0.060 |
Why?
|
| Protein Isoforms | 4 | 2018 | 1697 | 0.060 |
Why?
|
| Nervous System Malformations | 1 | 2007 | 244 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.060 |
Why?
|
| Transfection | 7 | 2012 | 5765 | 0.060 |
Why?
|
| Hemangioma, Cavernous | 2 | 1995 | 107 | 0.060 |
Why?
|
| Heart Arrest | 1 | 2015 | 1513 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 5672 | 0.060 |
Why?
|
| Aortic Valve | 1 | 2015 | 1955 | 0.060 |
Why?
|
| Valine | 1 | 2006 | 408 | 0.060 |
Why?
|
| Serine | 1 | 2008 | 830 | 0.060 |
Why?
|
| Microarray Analysis | 3 | 2014 | 748 | 0.060 |
Why?
|
| Cyclosporins | 1 | 1984 | 216 | 0.060 |
Why?
|
| Heme | 4 | 1982 | 313 | 0.060 |
Why?
|
| Cell Aggregation | 1 | 2005 | 239 | 0.060 |
Why?
|
| Genomic Structural Variation | 1 | 2024 | 68 | 0.060 |
Why?
|
| Retina | 1 | 1995 | 2655 | 0.060 |
Why?
|
| Psychotic Disorders | 1 | 2019 | 3220 | 0.060 |
Why?
|
| Solubility | 4 | 2000 | 1089 | 0.060 |
Why?
|
| Epilepsy | 2 | 2011 | 3303 | 0.060 |
Why?
|
| Choroid | 1 | 1986 | 360 | 0.060 |
Why?
|
| beta Catenin | 1 | 2009 | 1039 | 0.060 |
Why?
|
| Dopamine | 1 | 2011 | 1606 | 0.060 |
Why?
|
| Urogenital Abnormalities | 1 | 2007 | 261 | 0.060 |
Why?
|
| Aging | 6 | 2016 | 8700 | 0.060 |
Why?
|
| Methionine | 1 | 2006 | 572 | 0.060 |
Why?
|
| Myosin Type V | 1 | 2004 | 32 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 3 | 1994 | 3839 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2020 | 2456 | 0.060 |
Why?
|
| Phosphorylation | 4 | 2023 | 8311 | 0.060 |
Why?
|
| src-Family Kinases | 1 | 2006 | 535 | 0.060 |
Why?
|
| Metaphase | 3 | 1992 | 145 | 0.060 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2010 | 781 | 0.060 |
Why?
|
| Microsatellite Instability | 1 | 2007 | 716 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2020 | 10754 | 0.050 |
Why?
|
| Sirolimus | 3 | 2020 | 1533 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 1994 | 127 | 0.050 |
Why?
|
| Superoxide Dismutase | 4 | 1994 | 593 | 0.050 |
Why?
|
| Blotting, Western | 7 | 2013 | 5034 | 0.050 |
Why?
|
| Siblings | 3 | 2017 | 824 | 0.050 |
Why?
|
| Urinary Tract | 1 | 2007 | 313 | 0.050 |
Why?
|
| Sex Characteristics | 3 | 2011 | 2637 | 0.050 |
Why?
|
| Infant, Newborn | 7 | 2016 | 26183 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2007 | 699 | 0.050 |
Why?
|
| Replication Origin | 1 | 2003 | 77 | 0.050 |
Why?
|
| Receptors, Neuropeptide | 1 | 2003 | 106 | 0.050 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2007 | 437 | 0.050 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2010 | 893 | 0.050 |
Why?
|
| Immunoprecipitation | 3 | 2012 | 876 | 0.050 |
Why?
|
| Conserved Sequence | 3 | 2002 | 1162 | 0.050 |
Why?
|
| Receptors, AMPA | 1 | 2024 | 335 | 0.050 |
Why?
|
| alpha-Synuclein | 2 | 2008 | 752 | 0.050 |
Why?
|
| Ocular Motility Disorders | 1 | 2004 | 144 | 0.050 |
Why?
|
| Protein Prenylation | 1 | 2002 | 70 | 0.050 |
Why?
|
| Cricetulus | 6 | 1992 | 814 | 0.050 |
Why?
|
| Parkinsonian Disorders | 1 | 2005 | 285 | 0.050 |
Why?
|
| Extracellular Matrix Proteins | 3 | 2011 | 829 | 0.050 |
Why?
|
| Intermediate Filament Proteins | 2 | 2012 | 262 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 4 | 2015 | 656 | 0.050 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2007 | 610 | 0.050 |
Why?
|
| Mice, Inbred Strains | 3 | 1992 | 1759 | 0.050 |
Why?
|
| Gonadotropins | 1 | 2003 | 241 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 2474 | 0.050 |
Why?
|
| Benzamides | 2 | 2020 | 1371 | 0.050 |
Why?
|
| Reward | 1 | 2009 | 971 | 0.050 |
Why?
|
| Internet | 1 | 2015 | 3094 | 0.050 |
Why?
|
| Arousal | 1 | 2008 | 1171 | 0.050 |
Why?
|
| Pattern Recognition, Visual | 1 | 2008 | 824 | 0.050 |
Why?
|
| Oligonucleotides | 2 | 2004 | 566 | 0.050 |
Why?
|
| Myosin Heavy Chains | 1 | 2004 | 404 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2009 | 2916 | 0.050 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 1995 | 366 | 0.050 |
Why?
|
| Apolipoproteins E | 4 | 1996 | 1443 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 3 | 1997 | 420 | 0.050 |
Why?
|
| Mice, Knockout | 6 | 2020 | 14388 | 0.050 |
Why?
|
| Pancreatitis | 1 | 2009 | 1097 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2003 | 485 | 0.050 |
Why?
|
| Ovary | 4 | 2014 | 959 | 0.050 |
Why?
|
| Species Specificity | 2 | 1998 | 2410 | 0.050 |
Why?
|
| Immunohistochemistry | 9 | 2012 | 11069 | 0.050 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2002 | 163 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3599 | 0.050 |
Why?
|
| Age Factors | 10 | 2016 | 18381 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2005 | 718 | 0.050 |
Why?
|
| Probability | 3 | 2003 | 2475 | 0.050 |
Why?
|
| Pseudogenes | 3 | 2003 | 104 | 0.050 |
Why?
|
| Protein Conformation | 3 | 1999 | 3965 | 0.050 |
Why?
|
| Apoptosis | 6 | 2018 | 9476 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2002 | 433 | 0.050 |
Why?
|
| HeLa Cells | 3 | 2002 | 3088 | 0.050 |
Why?
|
| Receptor, EphA2 | 1 | 2020 | 41 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2005 | 734 | 0.050 |
Why?
|
| tau Proteins | 2 | 2008 | 2093 | 0.050 |
Why?
|
| Italy | 3 | 2006 | 842 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2004 | 3730 | 0.050 |
Why?
|
| Hemin | 1 | 1980 | 51 | 0.050 |
Why?
|
| Cluster Analysis | 3 | 2015 | 2703 | 0.040 |
Why?
|
| Receptors, Immunologic | 1 | 2007 | 1409 | 0.040 |
Why?
|
| Glutamine | 2 | 2002 | 576 | 0.040 |
Why?
|
| Genetics, Population | 2 | 2018 | 935 | 0.040 |
Why?
|
| Fetal Diseases | 3 | 2012 | 913 | 0.040 |
Why?
|
| Organic Chemicals | 1 | 2021 | 210 | 0.040 |
Why?
|
| Body Patterning | 2 | 2017 | 632 | 0.040 |
Why?
|
| Research | 2 | 2002 | 1977 | 0.040 |
Why?
|
| Liver | 1 | 2016 | 7512 | 0.040 |
Why?
|
| Frameshift Mutation | 2 | 1999 | 392 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 8 | 2015 | 22117 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2002 | 927 | 0.040 |
Why?
|
| Dimethyl Sulfoxide | 6 | 1982 | 251 | 0.040 |
Why?
|
| Recombinant Proteins | 5 | 1999 | 6520 | 0.040 |
Why?
|
| Benzoxazoles | 1 | 2020 | 90 | 0.040 |
Why?
|
| Hemoglobins | 3 | 1982 | 1524 | 0.040 |
Why?
|
| RNA Interference | 3 | 2017 | 2829 | 0.040 |
Why?
|
| Attitude to Health | 1 | 2008 | 2025 | 0.040 |
Why?
|
| Pigmentation | 2 | 2011 | 144 | 0.040 |
Why?
|
| Kinetics | 5 | 1994 | 6370 | 0.040 |
Why?
|
| Insect Proteins | 2 | 2000 | 254 | 0.040 |
Why?
|
| International Cooperation | 1 | 2006 | 1422 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 1333 | 0.040 |
Why?
|
| Nondisjunction, Genetic | 3 | 1992 | 24 | 0.040 |
Why?
|
| I-kappa B Kinase | 1 | 2001 | 249 | 0.040 |
Why?
|
| Protein Biosynthesis | 3 | 1996 | 2100 | 0.040 |
Why?
|
| PC12 Cells | 2 | 2014 | 317 | 0.040 |
Why?
|
| ras GTPase-Activating Proteins | 2 | 1997 | 94 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2009 | 2985 | 0.040 |
Why?
|
| Bipolar Disorder | 2 | 2015 | 5091 | 0.040 |
Why?
|
| Europe | 3 | 2012 | 3415 | 0.040 |
Why?
|
| Sex Factors | 8 | 2008 | 10549 | 0.040 |
Why?
|
| Receptors, Melatonin | 2 | 1995 | 31 | 0.040 |
Why?
|
| Cyclin D1 | 2 | 2012 | 451 | 0.040 |
Why?
|
| Genetic Vectors | 5 | 2016 | 3392 | 0.040 |
Why?
|
| Neuroprotective Agents | 3 | 2014 | 957 | 0.040 |
Why?
|
| Purines | 2 | 1987 | 606 | 0.040 |
Why?
|
| Spinocerebellar Degenerations | 2 | 1996 | 44 | 0.040 |
Why?
|
| Antineoplastic Agents | 3 | 2018 | 13635 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10203 | 0.040 |
Why?
|
| Triazines | 1 | 2020 | 311 | 0.040 |
Why?
|
| Mitosis | 2 | 1999 | 1187 | 0.040 |
Why?
|
| TATA-Box Binding Protein | 1 | 1998 | 99 | 0.040 |
Why?
|
| Occupational Diseases | 1 | 2006 | 1490 | 0.040 |
Why?
|
| Oncogenes | 4 | 1988 | 1220 | 0.040 |
Why?
|
| Single Parent | 1 | 1998 | 32 | 0.040 |
Why?
|
| Collagenases | 1 | 1998 | 222 | 0.040 |
Why?
|
| Myotonic Dystrophy | 2 | 1996 | 78 | 0.040 |
Why?
|
| United States | 6 | 2017 | 72292 | 0.040 |
Why?
|
| Anxiety | 1 | 2013 | 4573 | 0.040 |
Why?
|
| Oocytes | 2 | 1993 | 1166 | 0.040 |
Why?
|
| Lysine | 1 | 2022 | 993 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2015 | 2358 | 0.040 |
Why?
|
| Transglutaminases | 1 | 1999 | 196 | 0.040 |
Why?
|
| Binding Sites | 5 | 2014 | 6051 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2016 | 12942 | 0.040 |
Why?
|
| Telecommunications | 1 | 1998 | 79 | 0.040 |
Why?
|
| Genes, p53 | 3 | 1998 | 712 | 0.040 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2017 | 29 | 0.040 |
Why?
|
| Synaptophysin | 1 | 2017 | 139 | 0.040 |
Why?
|
| Vestibular Nerve | 1 | 1997 | 101 | 0.040 |
Why?
|
| Emotions | 1 | 2009 | 2741 | 0.040 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2017 | 54 | 0.040 |
Why?
|
| Cytoplasm | 2 | 2000 | 1503 | 0.040 |
Why?
|
| Gastrula | 1 | 1997 | 82 | 0.040 |
Why?
|
| Organ Size | 2 | 2012 | 2252 | 0.040 |
Why?
|
| Methylation | 3 | 2014 | 1077 | 0.040 |
Why?
|
| Neoplasms, Experimental | 2 | 1998 | 1226 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2010 | 460 | 0.030 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 1996 | 38 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2011 | 726 | 0.030 |
Why?
|
| Heart Defects, Congenital | 2 | 2012 | 4671 | 0.030 |
Why?
|
| Spinal Neoplasms | 3 | 2000 | 703 | 0.030 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 1997 | 134 | 0.030 |
Why?
|
| Galactosylceramides | 1 | 1996 | 92 | 0.030 |
Why?
|
| Up-Regulation | 3 | 2012 | 4117 | 0.030 |
Why?
|
| Patient Selection | 1 | 2008 | 4237 | 0.030 |
Why?
|
| Pyridazines | 1 | 2018 | 201 | 0.030 |
Why?
|
| Genetic Counseling | 3 | 1992 | 627 | 0.030 |
Why?
|
| Apraxias | 1 | 2016 | 59 | 0.030 |
Why?
|
| Imidazoles | 1 | 1982 | 1175 | 0.030 |
Why?
|
| Cell Membrane | 4 | 2005 | 3680 | 0.030 |
Why?
|
| Embryo, Mammalian | 3 | 2012 | 1670 | 0.030 |
Why?
|
| Wales | 2 | 1986 | 87 | 0.030 |
Why?
|
| Occupational Exposure | 1 | 2006 | 1813 | 0.030 |
Why?
|
| Odds Ratio | 4 | 2015 | 9644 | 0.030 |
Why?
|
| Dinucleotide Repeats | 1 | 1995 | 29 | 0.030 |
Why?
|
| Chorionic Villi Sampling | 1 | 1995 | 35 | 0.030 |
Why?
|
| RNA, Complementary | 2 | 1993 | 45 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1996 | 240 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2016 | 145 | 0.030 |
Why?
|
| Inflammation | 1 | 2015 | 10759 | 0.030 |
Why?
|
| Long-Term Potentiation | 1 | 2017 | 290 | 0.030 |
Why?
|
| Prevalence | 5 | 2015 | 15702 | 0.030 |
Why?
|
| Embryo Loss | 1 | 2015 | 55 | 0.030 |
Why?
|
| Diencephalon | 1 | 1995 | 54 | 0.030 |
Why?
|
| Whole Body Imaging | 1 | 2018 | 283 | 0.030 |
Why?
|
| Amniocentesis | 1 | 1995 | 115 | 0.030 |
Why?
|
| Micrognathism | 1 | 2016 | 63 | 0.030 |
Why?
|
| Prefrontal Cortex | 2 | 2014 | 2219 | 0.030 |
Why?
|
| North America | 2 | 2011 | 1273 | 0.030 |
Why?
|
| Decision Making | 1 | 2009 | 3919 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2018 | 2916 | 0.030 |
Why?
|
| Proteomics | 2 | 2021 | 3836 | 0.030 |
Why?
|
| Hemangiopericytoma | 1 | 1995 | 71 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2803 | 0.030 |
Why?
|
| Risk Factors | 9 | 2019 | 74128 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2019 | 1525 | 0.030 |
Why?
|
| Meiosis | 4 | 1999 | 327 | 0.030 |
Why?
|
| 5' Untranslated Regions | 1 | 2016 | 253 | 0.030 |
Why?
|
| Stochastic Processes | 1 | 1976 | 355 | 0.030 |
Why?
|
| Chimerism | 1 | 2016 | 155 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2016 | 354 | 0.030 |
Why?
|
| Sperm Count | 1 | 2016 | 229 | 0.030 |
Why?
|
| Portugal | 1 | 2015 | 91 | 0.030 |
Why?
|
| Pregnancy | 8 | 2016 | 29869 | 0.030 |
Why?
|
| Levodopa | 1 | 1996 | 222 | 0.030 |
Why?
|
| Otolithic Membrane | 1 | 2014 | 38 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 1998 | 5780 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 1992 | 3410 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2017 | 982 | 0.030 |
Why?
|
| Antiparkinson Agents | 1 | 1996 | 184 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 1998 | 564 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2002 | 2202 | 0.030 |
Why?
|
| Hominidae | 1 | 1995 | 67 | 0.030 |
Why?
|
| Base Pairing | 1 | 2015 | 140 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2013 | 1703 | 0.030 |
Why?
|
| Cell Division | 6 | 1996 | 4457 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2008 | 3882 | 0.030 |
Why?
|
| Longitudinal Studies | 3 | 2016 | 14599 | 0.030 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1994 | 68 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2008 | 7995 | 0.030 |
Why?
|
| Histological Techniques | 1 | 1995 | 194 | 0.030 |
Why?
|
| Colorectal Neoplasms | 3 | 2000 | 6927 | 0.030 |
Why?
|
| Systems Biology | 1 | 2018 | 481 | 0.030 |
Why?
|
| Ciliary Body | 1 | 2015 | 167 | 0.030 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2015 | 141 | 0.030 |
Why?
|
| Neurotransmitter Agents | 2 | 2010 | 665 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2012 | 6223 | 0.030 |
Why?
|
| Paralysis | 1 | 1996 | 250 | 0.030 |
Why?
|
| Genes, ras | 2 | 1995 | 654 | 0.030 |
Why?
|
| Multiprotein Complexes | 2 | 2012 | 1118 | 0.030 |
Why?
|
| Gemfibrozil | 1 | 2013 | 30 | 0.030 |
Why?
|
| Achondroplasia | 1 | 1994 | 28 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 1827 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2002 | 2481 | 0.030 |
Why?
|
| Oligodendroglioma | 1 | 1995 | 278 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2014 | 1745 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1995 | 328 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 2016 | 961 | 0.030 |
Why?
|
| Neoplasms | 6 | 2014 | 22131 | 0.030 |
Why?
|
| Mice, Inbred CBA | 1 | 1994 | 436 | 0.030 |
Why?
|
| Genes, fos | 1 | 1993 | 175 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 1 | 1996 | 870 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 2063 | 0.030 |
Why?
|
| Fenofibrate | 1 | 2013 | 87 | 0.030 |
Why?
|
| Multigene Family | 1 | 2016 | 1076 | 0.030 |
Why?
|
| Paternal Age | 2 | 1992 | 87 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1995 | 457 | 0.030 |
Why?
|
| CpG Islands | 2 | 2011 | 1192 | 0.030 |
Why?
|
| Keratins | 1 | 1995 | 498 | 0.030 |
Why?
|
| Rhabdoid Tumor | 1 | 1995 | 210 | 0.030 |
Why?
|
| Blood Proteins | 4 | 2005 | 1172 | 0.030 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2013 | 34 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2018 | 2625 | 0.030 |
Why?
|
| Branchial Region | 1 | 2013 | 36 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-4A | 1 | 2013 | 23 | 0.030 |
Why?
|
| Lentivirus | 1 | 2016 | 507 | 0.030 |
Why?
|
| Mothers | 2 | 2007 | 2194 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 1998 | 896 | 0.030 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 1995 | 246 | 0.030 |
Why?
|
| Atrophy | 4 | 2007 | 1632 | 0.030 |
Why?
|
| Cell Survival | 2 | 2018 | 5780 | 0.030 |
Why?
|
| Quinolines | 1 | 2018 | 764 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2016 | 587 | 0.030 |
Why?
|
| Suppression, Genetic | 1 | 2013 | 190 | 0.030 |
Why?
|
| Gene Order | 1 | 2012 | 169 | 0.030 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2013 | 170 | 0.030 |
Why?
|
| Serine Endopeptidases | 1 | 1998 | 1022 | 0.030 |
Why?
|
| Disease Progression | 4 | 2015 | 13495 | 0.030 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1993 | 317 | 0.030 |
Why?
|
| Centromere | 3 | 1995 | 212 | 0.030 |
Why?
|
| Leukemia, Experimental | 3 | 1982 | 225 | 0.030 |
Why?
|
| Teratoma | 1 | 1995 | 404 | 0.030 |
Why?
|
| Linear Models | 2 | 2015 | 5866 | 0.030 |
Why?
|
| RNA, Neoplasm | 2 | 1994 | 749 | 0.030 |
Why?
|
| Europe, Eastern | 1 | 1992 | 72 | 0.030 |
Why?
|
| Maternal Age | 3 | 1992 | 809 | 0.030 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 1992 | 106 | 0.030 |
Why?
|
| Interneurons | 1 | 1997 | 582 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1133 | 0.020 |
Why?
|
| Psychomotor Disorders | 1 | 2013 | 149 | 0.020 |
Why?
|
| Facies | 1 | 2013 | 222 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2012 | 129 | 0.020 |
Why?
|
| PAX2 Transcription Factor | 1 | 2012 | 86 | 0.020 |
Why?
|
| Leukocytes | 3 | 1990 | 2024 | 0.020 |
Why?
|
| Golgi Apparatus | 1 | 2013 | 404 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 852 | 0.020 |
Why?
|
| COS Cells | 3 | 1999 | 1130 | 0.020 |
Why?
|
| Hemizygote | 1 | 2011 | 28 | 0.020 |
Why?
|
| Wnt1 Protein | 1 | 2012 | 121 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2021 | 2425 | 0.020 |
Why?
|
| Time Factors | 4 | 2021 | 39908 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2016 | 1575 | 0.020 |
Why?
|
| Dogs | 1 | 2017 | 3837 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 1995 | 733 | 0.020 |
Why?
|
| Cadaver | 2 | 2012 | 1358 | 0.020 |
Why?
|
| Random Allocation | 2 | 2008 | 2392 | 0.020 |
Why?
|
| Facial Bones | 1 | 1993 | 208 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2018 | 1892 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2012 | 151 | 0.020 |
Why?
|
| Plasmids | 3 | 2005 | 2265 | 0.020 |
Why?
|
| Gliosis | 1 | 2012 | 245 | 0.020 |
Why?
|
| Growth and Development | 1 | 2011 | 47 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2012 | 265 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 8998 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2009 | 5369 | 0.020 |
Why?
|
| Xenopus | 1 | 1993 | 711 | 0.020 |
Why?
|
| Face | 1 | 2017 | 1026 | 0.020 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2013 | 251 | 0.020 |
Why?
|
| Cell Movement | 2 | 2020 | 5201 | 0.020 |
Why?
|
| Naphthyridines | 1 | 2012 | 143 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 2447 | 0.020 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2013 | 415 | 0.020 |
Why?
|
| Basal Ganglia | 2 | 2010 | 554 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2013 | 1262 | 0.020 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2013 | 484 | 0.020 |
Why?
|
| Physicians | 1 | 2008 | 4583 | 0.020 |
Why?
|
| Inclusion Bodies | 2 | 2004 | 281 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2018 | 36401 | 0.020 |
Why?
|
| Fibroblast Growth Factor 8 | 1 | 2010 | 62 | 0.020 |
Why?
|
| Tunisia | 1 | 2010 | 36 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 1988 | 192 | 0.020 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 1 | 2010 | 29 | 0.020 |
Why?
|
| RNA Stability | 1 | 2012 | 320 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 2013 | 360 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 634 | 0.020 |
Why?
|
| Synapses | 2 | 2017 | 1754 | 0.020 |
Why?
|
| History, 19th Century | 1 | 1993 | 718 | 0.020 |
Why?
|
| Zinc | 1 | 1994 | 687 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2020 | 2008 | 0.020 |
Why?
|
| Dipeptides | 1 | 2012 | 391 | 0.020 |
Why?
|
| Specimen Handling | 1 | 1995 | 701 | 0.020 |
Why?
|
| Cell Respiration | 1 | 2010 | 201 | 0.020 |
Why?
|
| Gastrointestinal Hormones | 1 | 2010 | 101 | 0.020 |
Why?
|
| Mixed Function Oxygenases | 1 | 1991 | 265 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 384 | 0.020 |
Why?
|
| Genes, Synthetic | 1 | 1990 | 88 | 0.020 |
Why?
|
| RNA, Ribosomal | 2 | 1982 | 227 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 1993 | 1089 | 0.020 |
Why?
|
| Larva | 1 | 2011 | 509 | 0.020 |
Why?
|
| Chromosome Fragility | 2 | 2003 | 16 | 0.020 |
Why?
|
| Amino Acids | 1 | 2016 | 1718 | 0.020 |
Why?
|
| Chromosome Fragile Sites | 2 | 2003 | 26 | 0.020 |
Why?
|
| Cerebral Ventricles | 1 | 2012 | 542 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2019 | 5671 | 0.020 |
Why?
|
| Monoamine Oxidase | 1 | 1989 | 181 | 0.020 |
Why?
|
| Chromosomes, Mammalian | 1 | 2010 | 147 | 0.020 |
Why?
|
| Neurosecretory Systems | 1 | 2011 | 223 | 0.020 |
Why?
|
| Axons | 2 | 2014 | 1671 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 481 | 0.020 |
Why?
|
| Menstruation | 1 | 2011 | 306 | 0.020 |
Why?
|
| Nursing Methodology Research | 1 | 2008 | 64 | 0.020 |
Why?
|
| Models, Statistical | 3 | 2009 | 5074 | 0.020 |
Why?
|
| Thioguanine | 2 | 1980 | 45 | 0.020 |
Why?
|
| Thalamus | 1 | 1995 | 1047 | 0.020 |
Why?
|
| Locomotion | 1 | 2011 | 388 | 0.020 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2010 | 137 | 0.020 |
Why?
|
| Prognosis | 2 | 2020 | 29601 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2017 | 1600 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1991 | 412 | 0.020 |
Why?
|
| Epigenesis, Genetic | 2 | 2013 | 3794 | 0.020 |
Why?
|
| Monosomy | 1 | 1988 | 52 | 0.020 |
Why?
|
| Reference Values | 4 | 1999 | 4919 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2012 | 905 | 0.020 |
Why?
|
| Carbon-Nitrogen Ligases | 1 | 1988 | 27 | 0.020 |
Why?
|
| Cerebellar Ataxia | 1 | 1990 | 150 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2018 | 1977 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2006 | 23974 | 0.020 |
Why?
|
| DNA, Ribosomal | 2 | 1987 | 299 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2015 | 1503 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2006 | 1692 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2011 | 820 | 0.020 |
Why?
|
| Brain Stem | 1 | 1993 | 858 | 0.020 |
Why?
|
| Lysosomes | 1 | 2013 | 925 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 1992 | 552 | 0.020 |
Why?
|
| Principal Component Analysis | 1 | 2011 | 943 | 0.020 |
Why?
|
| Social Support | 1 | 1998 | 2174 | 0.020 |
Why?
|
| Death, Sudden | 1 | 2010 | 301 | 0.020 |
Why?
|
| Genes, Insect | 2 | 2000 | 264 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2016 | 1808 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 1993 | 1152 | 0.020 |
Why?
|
| Telomerase | 1 | 2013 | 744 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 6188 | 0.020 |
Why?
|
| Genes, X-Linked | 1 | 2008 | 128 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 3 | 1998 | 2674 | 0.020 |
Why?
|
| Hepatolenticular Degeneration | 1 | 1988 | 72 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2013 | 1132 | 0.020 |
Why?
|
| Phosphofructokinase-1 | 1 | 1987 | 50 | 0.020 |
Why?
|
| Hostility | 1 | 2008 | 183 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2018 | 3546 | 0.020 |
Why?
|
| Human Genome Project | 1 | 2008 | 200 | 0.020 |
Why?
|
| Circadian Rhythm | 2 | 2016 | 2569 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2008 | 544 | 0.020 |
Why?
|
| Nurse's Role | 1 | 2008 | 188 | 0.020 |
Why?
|
| Amenorrhea | 1 | 2011 | 483 | 0.020 |
Why?
|
| Birth Order | 1 | 2007 | 95 | 0.020 |
Why?
|
| Ligases | 2 | 1988 | 333 | 0.020 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1986 | 32 | 0.020 |
Why?
|
| Chromosomes | 3 | 1999 | 578 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 2008 | 623 | 0.020 |
Why?
|
| Chromosomes, Artificial, Yeast | 2 | 1997 | 113 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2006 | 110 | 0.020 |
Why?
|
| Transgenes | 1 | 2010 | 1008 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 1998 | 2527 | 0.020 |
Why?
|
| Frontal Lobe | 2 | 2009 | 1418 | 0.020 |
Why?
|
| Glucose | 3 | 1992 | 4345 | 0.020 |
Why?
|
| DNA Repair | 1 | 2015 | 2043 | 0.020 |
Why?
|
| Swine | 1 | 2016 | 5908 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 669 | 0.020 |
Why?
|
| Eye Neoplasms | 1 | 1988 | 307 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2005 | 42 | 0.020 |
Why?
|
| Phylogeny | 1 | 1993 | 2805 | 0.020 |
Why?
|
| Models, Animal | 2 | 2003 | 2108 | 0.020 |
Why?
|
| Gene Amplification | 3 | 1995 | 1087 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2008 | 1018 | 0.020 |
Why?
|
| Carrier State | 1 | 2009 | 522 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2009 | 678 | 0.020 |
Why?
|
| Models, Molecular | 1 | 1995 | 5433 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 4 | 1999 | 8165 | 0.020 |
Why?
|
| Risk | 3 | 1986 | 9603 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2005 | 247 | 0.020 |
Why?
|
| Body Height | 1 | 2011 | 1565 | 0.020 |
Why?
|
| Parents | 4 | 2007 | 3563 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2005 | 87 | 0.020 |
Why?
|
| Retinoblastoma | 1 | 1988 | 319 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2010 | 6339 | 0.020 |
Why?
|
| Canavanine | 1 | 1984 | 14 | 0.020 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2004 | 101 | 0.020 |
Why?
|
| Argininosuccinate Synthase | 1 | 1984 | 16 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2006 | 740 | 0.010 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 2 | 1997 | 141 | 0.010 |
Why?
|
| Ethics | 1 | 1985 | 94 | 0.010 |
Why?
|
| Shigella | 1 | 2005 | 68 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 3 | 1992 | 1122 | 0.010 |
Why?
|
| Ureter | 1 | 2007 | 368 | 0.010 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 1754 | 0.010 |
Why?
|
| Sweden | 1 | 1987 | 1379 | 0.010 |
Why?
|
| Fathers | 1 | 2007 | 375 | 0.010 |
Why?
|
| Clone Cells | 2 | 1999 | 1657 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2005 | 422 | 0.010 |
Why?
|
| MSX1 Transcription Factor | 1 | 2004 | 53 | 0.010 |
Why?
|
| Protease Inhibitors | 1 | 1988 | 753 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 2639 | 0.010 |
Why?
|
| Diagnosis, Differential | 3 | 1995 | 12966 | 0.010 |
Why?
|
| Oligonucleotide Probes | 2 | 1996 | 416 | 0.010 |
Why?
|
| Logistic Models | 2 | 2008 | 13248 | 0.010 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 2 | 1995 | 106 | 0.010 |
Why?
|
| Thalamic Nuclei | 2 | 1995 | 111 | 0.010 |
Why?
|
| Gonads | 1 | 2003 | 109 | 0.010 |
Why?
|
| Genes, Overlapping | 1 | 2003 | 36 | 0.010 |
Why?
|
| Astrocytes | 1 | 2011 | 1341 | 0.010 |
Why?
|
| Aneuploidy | 1 | 1987 | 552 | 0.010 |
Why?
|
| Euchromatin | 1 | 2003 | 54 | 0.010 |
Why?
|
| Meta-Analysis as Topic | 1 | 2008 | 1380 | 0.010 |
Why?
|
| AKR murine leukemia virus | 1 | 1982 | 3 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2003 | 168 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 20077 | 0.010 |
Why?
|
| Australia | 1 | 2006 | 1249 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 1987 | 1606 | 0.010 |
Why?
|
| Microscopy, Confocal | 2 | 2000 | 1970 | 0.010 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2007 | 789 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2003 | 250 | 0.010 |
Why?
|
| Moloney murine leukemia virus | 1 | 1982 | 109 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2012 | 2624 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 2015 | 3796 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1993 | 3998 | 0.010 |
Why?
|
| Leukemia Virus, Murine | 1 | 1982 | 94 | 0.010 |
Why?
|
| Choice Behavior | 1 | 2008 | 825 | 0.010 |
Why?
|
| Neural Pathways | 1 | 2013 | 3056 | 0.010 |
Why?
|
| Limb Deformities, Congenital | 1 | 2003 | 136 | 0.010 |
Why?
|
| 3T3 Cells | 2 | 1994 | 1085 | 0.010 |
Why?
|
| Retroelements | 1 | 2003 | 162 | 0.010 |
Why?
|
| Sexual Maturation | 1 | 2003 | 261 | 0.010 |
Why?
|
| Denmark | 1 | 2004 | 770 | 0.010 |
Why?
|
| Dopamine beta-Hydroxylase | 1 | 2001 | 74 | 0.010 |
Why?
|
| Breast | 1 | 2011 | 1963 | 0.010 |
Why?
|
| Memory, Short-Term | 1 | 2008 | 982 | 0.010 |
Why?
|
| Codon | 2 | 1994 | 600 | 0.010 |
Why?
|
| Amygdala | 1 | 2009 | 1353 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2010 | 1452 | 0.010 |
Why?
|
| Genes, Viral | 1 | 1982 | 649 | 0.010 |
Why?
|
| Apolipoprotein E4 | 2 | 1996 | 709 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 1996 | 3222 | 0.010 |
Why?
|
| Erythropoietin | 1 | 1986 | 719 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 2561 | 0.010 |
Why?
|
| Caspase 1 | 1 | 2002 | 226 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2002 | 311 | 0.010 |
Why?
|
| Williams Syndrome | 1 | 2003 | 194 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2009 | 2929 | 0.010 |
Why?
|
| Hypoxanthines | 2 | 1980 | 35 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2008 | 1400 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 1988 | 3611 | 0.010 |
Why?
|
| Cytidine Deaminase | 1 | 1982 | 243 | 0.010 |
Why?
|
| Neurology | 1 | 2008 | 784 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2016 | 54364 | 0.010 |
Why?
|
| Disclosure | 1 | 1986 | 747 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1995 | 12333 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 1990 | 2689 | 0.010 |
Why?
|
| Polydeoxyribonucleotides | 2 | 1992 | 136 | 0.010 |
Why?
|
| Glioblastoma | 1 | 1995 | 3481 | 0.010 |
Why?
|
| Friend murine leukemia virus | 1 | 1980 | 37 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2004 | 2467 | 0.010 |
Why?
|
| New England | 1 | 2003 | 1050 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 2000 | 183 | 0.010 |
Why?
|
| Spliceosomes | 1 | 2000 | 119 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1882 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2018 | 64572 | 0.010 |
Why?
|
| Boston | 2 | 2008 | 9313 | 0.010 |
Why?
|
| Structure-Activity Relationship | 2 | 1994 | 3074 | 0.010 |
Why?
|
| Muridae | 1 | 1999 | 56 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1993 | 4745 | 0.010 |
Why?
|
| Immune Sera | 1 | 2000 | 605 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2863 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 3 | 2005 | 9171 | 0.010 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 1999 | 124 | 0.010 |
Why?
|
| Melanoma | 2 | 1998 | 5696 | 0.010 |
Why?
|
| Genes, bcl-2 | 1 | 1999 | 119 | 0.010 |
Why?
|
| Health Surveys | 1 | 1989 | 4036 | 0.010 |
Why?
|
| Schwann Cells | 1 | 2000 | 196 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2011 | 3183 | 0.010 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 1999 | 201 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 12043 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2007 | 1807 | 0.010 |
Why?
|
| Motivation | 1 | 2008 | 2003 | 0.010 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 1998 | 63 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1986 | 1971 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2009 | 5863 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 1998 | 145 | 0.010 |
Why?
|
| Names | 1 | 1998 | 54 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1999 | 1141 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1998 | 364 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2006 | 2112 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 1738 | 0.010 |
Why?
|
| Hamartoma | 1 | 2000 | 236 | 0.010 |
Why?
|
| Endopeptidase Clp | 1 | 1998 | 42 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 1998 | 287 | 0.010 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2009 | 1727 | 0.010 |
Why?
|
| Environment | 1 | 2004 | 1123 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 1998 | 315 | 0.010 |
Why?
|
| Forecasting | 1 | 1987 | 2924 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2003 | 988 | 0.010 |
Why?
|
| Dimerization | 1 | 1999 | 890 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2011 | 5965 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1992 | 14649 | 0.010 |
Why?
|
| Japan | 2 | 1993 | 1372 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 2003 | 1077 | 0.010 |
Why?
|
| Transcription Factor AP-1 | 1 | 1998 | 319 | 0.010 |
Why?
|
| Oxygen | 1 | 2008 | 4226 | 0.010 |
Why?
|
| Gait | 1 | 2002 | 811 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2003 | 2635 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2009 | 4028 | 0.010 |
Why?
|
| Quality of Life | 1 | 2018 | 13359 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1999 | 685 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 3 | 1 | 1995 | 4 | 0.010 |
Why?
|
| Abortion, Eugenic | 1 | 1995 | 39 | 0.010 |
Why?
|
| Carcinoma, Lobular | 1 | 2000 | 480 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 1996 | 531 | 0.010 |
Why?
|
| Ectoderm | 1 | 1995 | 137 | 0.010 |
Why?
|
| Protein Phosphatase 1 | 1 | 1995 | 134 | 0.010 |
Why?
|
| Predictive Value of Tests | 2 | 1990 | 15250 | 0.010 |
Why?
|
| Contact Inhibition | 1 | 1994 | 46 | 0.010 |
Why?
|
| Breast Neoplasms | 2 | 2000 | 20988 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 1995 | 80 | 0.010 |
Why?
|
| Goals | 1 | 2000 | 708 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1996 | 309 | 0.010 |
Why?
|
| Bacteriophage lambda | 2 | 1988 | 142 | 0.010 |
Why?
|
| Skin | 1 | 2008 | 4472 | 0.010 |
Why?
|
| Dinucleoside Phosphates | 1 | 1994 | 68 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1997 | 563 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1998 | 1230 | 0.010 |
Why?
|
| Tissue Banks | 1 | 1995 | 184 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 4010 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 1 | 1997 | 517 | 0.010 |
Why?
|
| Pediatrics | 1 | 2008 | 3589 | 0.010 |
Why?
|
| Adenosine Triphosphatases | 1 | 1998 | 835 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1999 | 3591 | 0.010 |
Why?
|
| Research Design | 1 | 1989 | 6174 | 0.010 |
Why?
|
| Cell Count | 1 | 1997 | 1834 | 0.010 |
Why?
|
| Myotonia Congenita | 1 | 1992 | 16 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2000 | 1084 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2002 | 1589 | 0.010 |
Why?
|
| Poly A | 1 | 1992 | 181 | 0.010 |
Why?
|
| France | 1 | 1994 | 492 | 0.010 |
Why?
|
| Ear, External | 1 | 1993 | 165 | 0.010 |
Why?
|
| Drug Resistance | 2 | 1991 | 1594 | 0.010 |
Why?
|
| Axonal Transport | 1 | 1992 | 178 | 0.010 |
Why?
|
| Tenascin | 1 | 1992 | 61 | 0.010 |
Why?
|
| Mesoderm | 1 | 1995 | 674 | 0.010 |
Why?
|
| North Carolina | 1 | 1993 | 322 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 1993 | 316 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 80583 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1979 | 1946 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2009 | 20556 | 0.010 |
Why?
|
| GTPase-Activating Proteins | 1 | 1995 | 471 | 0.010 |
Why?
|
| ras Proteins | 1 | 1997 | 1054 | 0.010 |
Why?
|
| Neomycin | 1 | 1991 | 92 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 7044 | 0.010 |
Why?
|
| Rodentia | 1 | 1993 | 261 | 0.010 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 1991 | 222 | 0.010 |
Why?
|
| Colon | 1 | 1999 | 1791 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1994 | 697 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2007 | 6240 | 0.010 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1991 | 191 | 0.010 |
Why?
|
| Sex | 1 | 1991 | 53 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 1993 | 367 | 0.010 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 1991 | 107 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 1993 | 380 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 1995 | 2821 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1994 | 1229 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 14024 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 15829 | 0.010 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1989 | 16 | 0.010 |
Why?
|
| Limbic System | 1 | 1992 | 419 | 0.010 |
Why?
|
| Hernia, Inguinal | 1 | 1993 | 220 | 0.010 |
Why?
|
| Olivopontocerebellar Atrophies | 1 | 1989 | 19 | 0.010 |
Why?
|
| Mammals | 1 | 1995 | 1131 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 1992 | 635 | 0.010 |
Why?
|
| Abortion, Induced | 1 | 1995 | 461 | 0.010 |
Why?
|
| Fluorescence | 1 | 1992 | 756 | 0.010 |
Why?
|
| Respiration Disorders | 1 | 1993 | 367 | 0.010 |
Why?
|
| Putamen | 1 | 1990 | 292 | 0.010 |
Why?
|
| Cryopreservation | 1 | 1995 | 728 | 0.010 |
Why?
|
| Globus Pallidus | 1 | 1990 | 250 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1989 | 226 | 0.010 |
Why?
|
| Survival Rate | 1 | 2003 | 12719 | 0.000 |
Why?
|
| Operator Regions, Genetic | 1 | 1988 | 33 | 0.000 |
Why?
|
| Trypsin Inhibitors | 1 | 1988 | 34 | 0.000 |
Why?
|
| Retroviridae | 1 | 1991 | 851 | 0.000 |
Why?
|
| Anemia, Macrocytic | 1 | 1988 | 53 | 0.000 |
Why?
|
| Gelsolin | 1 | 1989 | 189 | 0.000 |
Why?
|
| Likelihood Functions | 1 | 1992 | 991 | 0.000 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1988 | 30 | 0.000 |
Why?
|
| Finland | 1 | 1990 | 607 | 0.000 |
Why?
|
| Intestinal Mucosa | 1 | 1999 | 3031 | 0.000 |
Why?
|
| Antibodies | 1 | 1996 | 2413 | 0.000 |
Why?
|
| Fetus | 1 | 1995 | 1862 | 0.000 |
Why?
|
| Deoxyribonuclease HindIII | 1 | 1987 | 14 | 0.000 |
Why?
|
| Methods | 1 | 1988 | 1065 | 0.000 |
Why?
|
| Hypothalamus | 1 | 1992 | 999 | 0.000 |
Why?
|
| Neurologic Examination | 1 | 1990 | 915 | 0.000 |
Why?
|
| Equipment Design | 1 | 1995 | 3501 | 0.000 |
Why?
|
| Neoplasm Invasiveness | 1 | 1995 | 3593 | 0.000 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1988 | 175 | 0.000 |
Why?
|
| Government Agencies | 1 | 1987 | 160 | 0.000 |
Why?
|
| Locus Coeruleus | 1 | 1988 | 230 | 0.000 |
Why?
|
| Gestational Age | 1 | 1995 | 3577 | 0.000 |
Why?
|
| Gastroesophageal Reflux | 1 | 1993 | 821 | 0.000 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1993 | 1745 | 0.000 |
Why?
|
| Pregnancy Outcome | 1 | 1995 | 2921 | 0.000 |
Why?
|
| Survival Analysis | 1 | 1997 | 10072 | 0.000 |
Why?
|
| Colony-Forming Units Assay | 1 | 1984 | 351 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1995 | 4910 | 0.000 |
Why?
|
| Massachusetts | 1 | 1996 | 8835 | 0.000 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1996 | 3394 | 0.000 |
Why?
|
| Stem Cells | 1 | 1995 | 3514 | 0.000 |
Why?
|
| Carcinoma | 1 | 1994 | 2328 | 0.000 |
Why?
|
| 5-Methylcytosine | 1 | 1982 | 147 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1997 | 6635 | 0.000 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1992 | 6016 | 0.000 |
Why?
|
| Azacitidine | 1 | 1982 | 335 | 0.000 |
Why?
|
| Biometry | 1 | 1984 | 561 | 0.000 |
Why?
|
| Amyloidosis | 1 | 1987 | 815 | 0.000 |
Why?
|
| Databases, Factual | 1 | 1995 | 7963 | 0.000 |
Why?
|
| Butyrates | 1 | 1980 | 169 | 0.000 |
Why?
|
| Lung | 1 | 1996 | 9999 | 0.000 |
Why?
|
| Temperature | 1 | 1984 | 2224 | 0.000 |
Why?
|
| DNA, Viral | 1 | 1982 | 2194 | 0.000 |
Why?
|
| Viral Proteins | 1 | 1980 | 1799 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1988 | 39062 | 0.000 |
Why?
|